Latest Equity Offer News

Anteris Technologies posted a $51.7 million loss in H1 2026 amid ramped-up R&D and clinical trial activity, supported by a $320 million capital raise and Medicare reimbursement for its DurAVR heart valve trial.

Toubani Resources has successfully closed the retail tranche of its fully underwritten entitlement offer, securing approximately A$70 million to support its Kobada Gold Project development.

The Calmer Co International Ltd is raising up to $3.5 million through a 1-for-1 renounceable entitlement offer priced at $0.001 per share, including free attaching options exercisable at $0.002. The capital will fund debt repayment, inventory expansion, marketing, and product launches.

Almonty Industries has closed a US$700 million convertible senior notes offering, including a full US$100 million over-allotment exercise, bolstering its balance sheet to accelerate development of the Sangdong tungsten mine and secure a non-China supply chain for Western defence.

Whitefield Income Limited is raising up to A$108 million through a 2 for 5 entitlement offer priced at A$1.22 per share, aiming to boost its net asset value and expand its investor base.

Anteris Technologies Global Corp. has initiated an at-the-market equity offering to raise up to US$250 million, aiming to accelerate development of its DurAVR transcatheter heart valve and support general corporate needs.

Tanami Gold has launched a fully underwritten $70.5 million renounceable rights issue priced at 6 cents per share, aiming to finance its 50% stake in the Central Tanami Project. The offer is open to eligible shareholders across select jurisdictions and runs until 27 May 2026.

Marimaca Copper Corp. reported a robust cash position of $147.7 million in Q1 2026, driven by a C$409 million equity raise, supporting ongoing development of its Marimaca Project in Chile.

5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.

Barramundi Limited outperformed the S&P/ASX200 in April with a 4.4% gross return, boosted by NEXT DC’s landmark data centre deal and capital raise, while healthcare stocks faced headwinds from Cochlear’s profit downgrade.

Almonty Industries reported a 221% jump in Q1 2026 revenue to CAD 25.4 million, driven by soaring tungsten prices and ramp-up at its Sangdong Mine, while net loss narrowed to CAD 5.3 million amid strong operational cash flow.

NEXTDC urges eligible retail shareholders to participate in its A$1.5 billion entitlement offer, priced at a 10.9% discount, with a top-up facility available. The retail offer closes on 11 May 2026, following recent senior debt commitments that bolster its growth plans.